• Welcome to CymaBay
    Developing Breakthrough Medicines
    Improving quality of life
  • Welcome to CymaBay
    Developing Breakthrough Medicines
    Improving quality of life
  • Welcome to CymaBay
    Developing Breakthrough Medicines
    Improving quality of life
  • CymaBay is focused on developing breakthrough
    therapies for metabolic disease.

About CymaBay

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline.

Latest News